These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 33131044)
1. Extracellular Histones Inhibit Fibrinolysis through Noncovalent and Covalent Interactions with Fibrin. Locke M; Longstaff C Thromb Haemost; 2021 Apr; 121(4):464-476. PubMed ID: 33131044 [TBL] [Abstract][Full Text] [Related]
2. DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment. Varjú I; Longstaff C; Szabó L; Farkas ÁZ; Varga-Szabó VJ; Tanka-Salamon A; Machovich R; Kolev K Thromb Haemost; 2015 Jun; 113(6):1289-98. PubMed ID: 25789443 [TBL] [Abstract][Full Text] [Related]
3. Size- and charge-dependent modulation of the lytic susceptibility and mechanical stability of fibrin-histone clots by heparin and polyphosphate variants. Komorowicz E; Balázs N; Tanka-Salamon A; Varga Z; Szabó L; Bóta A; Longstaff C; Kolev K J Thromb Haemost; 2021 May; 19(5):1307-1318. PubMed ID: 33609065 [TBL] [Abstract][Full Text] [Related]
4. Cell-Free DNA Modulates Clot Structure and Impairs Fibrinolysis in Sepsis. Gould TJ; Vu TT; Stafford AR; Dwivedi DJ; Kim PY; Fox-Robichaud AE; Weitz JI; Liaw PC Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2544-53. PubMed ID: 26494232 [TBL] [Abstract][Full Text] [Related]
5. DNA and histones impair the mechanical stability and lytic susceptibility of fibrin formed by staphylocoagulase. Komorowicz E; Farkas VJ; Szabó L; Cherrington S; Thelwell C; Kolev K Front Immunol; 2023; 14():1233128. PubMed ID: 37662916 [TBL] [Abstract][Full Text] [Related]
6. Coagulation factor XIIIa is inactivated by plasmin. Hur WS; Mazinani N; Lu XJ; Britton HM; Byrnes JR; Wolberg AS; Kastrup CJ Blood; 2015 Nov; 126(20):2329-37. PubMed ID: 26359437 [TBL] [Abstract][Full Text] [Related]
7. Mechanical stability and fibrinolytic resistance of clots containing fibrin, DNA, and histones. Longstaff C; Varjú I; Sótonyi P; Szabó L; Krumrey M; Hoell A; Bóta A; Varga Z; Komorowicz E; Kolev K J Biol Chem; 2013 Mar; 288(10):6946-56. PubMed ID: 23293023 [TBL] [Abstract][Full Text] [Related]
8. DNA-bound elastase of neutrophil extracellular traps degrades plasminogen, reduces plasmin formation, and decreases fibrinolysis: proof of concept in septic shock plasma. Cruz DBD; Helms J; Aquino LR; Stiel L; Cougourdan L; Broussard C; Chafey P; Riès-Kautt M; Meziani F; Toti F; Gaussem P; Anglés-Cano E FASEB J; 2019 Dec; 33(12):14270-14280. PubMed ID: 31682515 [TBL] [Abstract][Full Text] [Related]
9. Neutralisation of the anti-coagulant effects of heparin by histones in blood plasma and purified systems. Longstaff C; Hogwood J; Gray E; Komorowicz E; Varjú I; Varga Z; Kolev K Thromb Haemost; 2016 Mar; 115(3):591-9. PubMed ID: 26632486 [TBL] [Abstract][Full Text] [Related]
10. Interactions between staphylokinase, plasmin(ogen), and fibrin. Staphylokinase discriminates between free plasminogen and plasminogen bound to partially degraded fibrin. Sakharov DV; Lijnen HR; Rijken DC J Biol Chem; 1996 Nov; 271(44):27912-8. PubMed ID: 8910391 [TBL] [Abstract][Full Text] [Related]
11. Interactions of heparin and a covalently-linked antithrombin-heparin complex with components of the fibrinolytic system. Chander A; Atkinson HM; Stevic I; Berry LR; Kim PY; Chan AK Thromb Haemost; 2013 Dec; 110(6):1180-8. PubMed ID: 24048327 [TBL] [Abstract][Full Text] [Related]
12. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity. Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071 [TBL] [Abstract][Full Text] [Related]
13. Effect of a synthetic carboxy-terminal peptide of alpha(2)-antiplasmin on urokinase-induced fibrinolysis. Lee KN; Jackson KW; McKee PA Thromb Res; 2002 Feb; 105(3):263-70. PubMed ID: 11927133 [TBL] [Abstract][Full Text] [Related]
14. Extracellular DNA and histones as thrombus stabiliser. Engelmann B Thromb Haemost; 2015 Jun; 113(6):1164. PubMed ID: 25947938 [No Abstract] [Full Text] [Related]
15. Factor XIII and venous thromboembolism. Bereczky Z; Muszbek L Semin Thromb Hemost; 2011 Apr; 37(3):305-14. PubMed ID: 21455864 [TBL] [Abstract][Full Text] [Related]
16. A hamster antibody to the mouse fibrinogen gamma chain inhibits platelet-fibrinogen interactions and FXIIIa-mediated fibrin cross-linking, and facilitates thrombolysis. Jirousková M; Smyth SS; Kudryk B; Coller BS Thromb Haemost; 2001 Oct; 86(4):1047-56. PubMed ID: 11686323 [TBL] [Abstract][Full Text] [Related]
17. The fibrinolytic system in man. Collen D; Lijnen HR Crit Rev Oncol Hematol; 1986; 4(3):249-301. PubMed ID: 2420482 [TBL] [Abstract][Full Text] [Related]
18. Integration of clotting and fibrinolysis: central role of platelets and factor XIIIa. Patalakh I; Revka O; Gołaszewska A; Bielicka N; Misztal T Biosci Rep; 2024 Sep; 44(9):. PubMed ID: 39212493 [TBL] [Abstract][Full Text] [Related]
19. Fibrin structures during tissue-type plasminogen activator-mediated fibrinolysis studied by laser light scattering: relation to fibrin enhancement of plasminogen activation. Bauer R; Hansen SL; Jones G; Suenson E; Thorsen S; Ogendal L Eur Biophys J; 1994; 23(4):239-52. PubMed ID: 7805626 [TBL] [Abstract][Full Text] [Related]
20. Down-regulation of activated factor XIII by polymorphonuclear granulocyte proteases within fibrin clot. Bagoly Z; Haramura G; Muszbek L Thromb Haemost; 2007 Aug; 98(2):359-67. PubMed ID: 17721618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]